MeSH term
Frequency | Condition_Probility | Anti-Bacterial Agents/*pharmacology | 8 | 6.0 |
Base Sequence | 2 | 0.0 |
Conjugation, Genetic | 2 | 11.0 |
Erythromycin/*pharmacology | 2 | 9.0 |
Humans | 19 | 0.0 |
*Macrolides | 5 | 13.0 |
Molecular Sequence Data | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 12 | 0.0 |
Tetracycline Resistance | 2 | 66.0 |
Virginiamycin/pharmacology | 4 | 100.0 |
Adult | 2 | 0.0 |
Anti-Bacterial Agents/pharmacology | 2 | 1.0 |
Drug Resistance, Microbial | 3 | 1.0 |
Erythromycin/pharmacology | 2 | 12.0 |
Female | 7 | 0.0 |
Male | 4 | 0.0 |
Microbial Sensitivity Tests | 5 | 2.0 |
Skin/*microbiology | 2 | 33.0 |
Virginiamycin/*pharmacology | 3 | 100.0 |
Drug Resistance, Microbial/genetics | 3 | 3.0 |
Comparative Study | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Lod Score | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Pedigree | 2 | 0.0 |
*Methicillin Resistance | 2 | 28.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Staphylococcus aureus/drug effects/*genetics | 2 | 66.0 |
Animals | 6 | 0.0 |
Mice | 4 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mice, Inbred C3H | 3 | 0.0 |
Phenotype | 3 | 0.0 |
*R Factors | 4 | 44.0 |
Magnetic Resonance Spectroscopy | 2 | 0.0 |
Child | 2 | 0.0 |
Streptococcus/*drug effects/genetics | 3 | 75.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
Animal Feed | 2 | 11.0 |
*Conjugation, Genetic | 2 | 33.0 |
DNA, Bacterial | 2 | 6.0 |
Feces/microbiology | 2 | 3.0 |
*Genes, Bacterial | 2 | 2.0 |
Leucomycins/*pharmacology | 2 | 66.0 |
Swine/microbiology | 2 | 33.0 |
